Parks J S, Tenore A, Bongiovanni A M, Kirkland R T
N Engl J Med. 1978 Mar 30;298(13):698-702. doi: 10.1056/NEJM197803302981302.
We studied endocrine function in three siblings with short stature and enlargement of the sella turcica. Sellar volumes were 5.9, 3.7 and 4.0 standard deviations above age-specific means. Computed tomography or pneumoencephalography showed full sellae without suprasellar extension. Basal thyrotropin levels were low despite hypothyroidism and increments were less than 3 micromicron per milliliter after thyrotropin-releasing hormone injection. Stimulated growth hormone levels were less than 5 ng per milliliter, declining to less than 2 ng per milliliter after thyroxine treatment. Both thyroxine and growth hormone treatments were required for rapid growth. Impaired thyrotropin responses to thyrotropin-releasing hormone distinguish these patients from most cases of idiopathic or familial deficiency of thyrotropin and growth hormone. Persistent deficiency of growth hormone during thyroxine treatment indicates that the defects is not limited to thyrotropin structure or release. The findings are compatible with either familial neoplasia of the anterior pituitary or a regulatory defect promoting anterior pituitary-cell hyperplasia and inhibiting thyrotropin and growth hormone release.
我们研究了三名身材矮小且蝶鞍扩大的兄弟姐妹的内分泌功能。蝶鞍体积比特定年龄均值高出5.9、3.7和4.0个标准差。计算机断层扫描或气脑造影显示蝶鞍饱满,无鞍上延伸。尽管存在甲状腺功能减退,但基础促甲状腺激素水平较低,注射促甲状腺激素释放激素后升高幅度小于每毫升3微克。刺激后的生长激素水平低于每毫升5纳克,甲状腺素治疗后降至低于每毫升2纳克。快速生长需要甲状腺素和生长激素治疗。促甲状腺激素对促甲状腺激素释放激素的反应受损,使这些患者与大多数特发性或家族性促甲状腺激素和生长激素缺乏症病例有所不同。甲状腺素治疗期间生长激素持续缺乏表明缺陷不限于促甲状腺激素的结构或释放。这些发现与垂体前叶的家族性肿瘤形成或促进垂体前叶细胞增生并抑制促甲状腺激素和生长激素释放的调节缺陷相符。